vimarsana.com
Home
Live Updates
Telesis Bio and Cellibre Announce Collaboration to Optimize
Telesis Bio and Cellibre Announce Collaboration to Optimize
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp DBC instrument
Agreement will allow researchers to streamline development of on-demand and automated production of CRISPR-Cas9 guide RNASAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader
Related Keywords
San Diego ,
California ,
United States ,
Bio Bioxp ,
Kostenloser Wertpapierhandel ,
Toddr Nelson ,
Charlie Schmidt ,
Ben Chiarelli ,
Exchange Commission ,
Gibson Assembly ,
Telesis Bio ,
Biological Converter ,
Digital To Biological Converter ,
Private Securities Litigation Reform Act ,
Telesis ,
Cellibre ,
Nnounce ,
Collaboration ,
Optimize ,
Development ,
Future ,
Ioxp ,
Instrument ,